Total Payments
$509.49
2024 Payments
$246.40
Companies
15
Transactions
29
Medicare Patients
668
Medicare Billing
$37,585
Payment Breakdown by Category
Food & Beverage$486.18 (95.4%)
Education$23.31 (4.6%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $486.18 | 28 | 95.4% |
| Education | $23.31 | 1 | 4.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $96.26 | 7 | $0 (2024) |
| Phathom Pharmaceuticals, Inc. | $84.54 | 3 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $65.40 | 3 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $45.05 | 3 | $0 (2024) |
| Lilly USA, LLC | $28.82 | 2 | $0 (2022) |
| SHIELD THERAPEUTICS INC | $27.29 | 2 | $0 (2024) |
| OPKO Pharmaceuticals, LLC | $23.31 | 1 | $0 (2023) |
| Merck Sharp & Dohme LLC | $23.11 | 1 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $21.53 | 1 | $0 (2021) |
| Indivior Inc. | $18.12 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $246.40 | 13 | Phathom Pharmaceuticals, Inc. ($84.54) |
| 2023 | $185.07 | 11 | GlaxoSmithKline, LLC. ($41.82) |
| 2022 | $29.36 | 2 | GlaxoSmithKline, LLC. ($15.90) |
| 2021 | $48.66 | 3 | Novartis Pharmaceuticals Corporation ($21.53) |
All Payment Transactions
29 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/18/2024 | SHIELD THERAPEUTICS INC | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $13.58 | General |
| Category: Hematology | ||||||
| 11/12/2024 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $13.85 | General |
| Category: Insulin Pump | ||||||
| 10/30/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $14.93 | General |
| Category: Cardiovascular | ||||||
| 10/01/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $13.50 | General |
| Category: RESPIRATORY | ||||||
| 09/23/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $28.95 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/10/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $15.55 | General |
| Category: NEUROSCIENCE | ||||||
| 09/04/2024 | SHIELD THERAPEUTICS INC | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $13.71 | General |
| Category: Hematology | ||||||
| 08/20/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $30.86 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/11/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $18.01 | General |
| Category: Inflammation | ||||||
| 04/11/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $25.61 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 03/28/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $24.73 | General |
| Category: GASTROENTEROLOGY | ||||||
| 02/14/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $13.27 | General |
| Category: RESPIRATORY | ||||||
| 02/13/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $19.85 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 12/12/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY, SHINGRIX | Food and Beverage | In-kind items and services | $13.97 | General |
| Category: RESPIRATORY | ||||||
| 10/26/2023 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $15.18 | General |
| Category: Cardiovascular | ||||||
| 10/11/2023 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $19.94 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 09/14/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY, SHINGRIX | Food and Beverage | In-kind items and services | $12.95 | General |
| Category: RESPIRATORY | ||||||
| 08/30/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $13.66 | General |
| Category: Diabetes | ||||||
| 07/25/2023 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Education | In-kind items and services | $23.31 | General |
| Category: NEPHROLOGY | ||||||
| 06/28/2023 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $14.94 | General |
| Category: Cardiovascular | ||||||
| 06/15/2023 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $18.12 | General |
| Category: OUD | ||||||
| 05/11/2023 | Merck Sharp & Dohme LLC | JANUVIA (Drug), VERQUVO, VERQUVO | Food and Beverage | In-kind items and services | $23.11 | General |
| Category: ENDOCRINOLOGY | ||||||
| 03/02/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.90 | General |
| Category: RESPIRATORY | ||||||
| 02/07/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $14.99 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 04/29/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.90 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 159 | 206 | $46,046 | $9,966 |
| 2022 | 4 | 172 | 198 | $41,148 | $8,754 |
| 2021 | 4 | 150 | 187 | $36,923 | $8,319 |
| 2020 | 5 | 187 | 235 | $31,894 | $10,547 |
Total Patients
668
Total Services
826
Medicare Billing
$37,585
Procedure Codes
16
All Medicare Procedures & Services
16 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 88 | 122 | $29,358 | $5,006 | 17.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 34 | 34 | $8,307 | $3,573 | 43.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 37 | 50 | $8,381 | $1,387 | 16.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 68 | 85 | $20,454 | $3,655 | 17.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 46 | 46 | $11,239 | $2,533 | 22.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 44 | 53 | $8,884 | $2,048 | 23.0% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2022 | 14 | 14 | $571.48 | $517.30 | 90.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 63 | 77 | $18,278 | $3,285 | 18.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 38 | 38 | $9,284 | $2,297 | 24.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 38 | 55 | $8,667 | $2,127 | 24.5% |
| 99211 | Established patient outpatient visit, minimal presenting problem | Office | 2021 | 11 | 17 | $693.94 | $609.93 | 87.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 79 | 118 | $15,282 | $4,519 | 29.6% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2020 | 15 | 15 | $4,608 | $2,126 | 46.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 20 | 20 | $5,127 | $1,917 | 37.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 52 | 61 | $5,347 | $1,608 | 30.1% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 21 | 21 | $1,530 | $376.31 | 24.6% |
About Joan Osswald, N.P
Joan Osswald, N.P is a Nurse Practitioner healthcare provider based in Buffalo, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/24/2006. The National Provider Identifier (NPI) number assigned to this provider is 1588686307.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Joan Osswald, N.P has received a total of $509.49 in payments from pharmaceutical and medical device companies, with $246.40 received in 2024. These payments were reported across 29 transactions from 15 companies. The most common payment nature is "Food and Beverage" ($486.18).
As a Medicare-enrolled provider, Osswald has provided services to 668 Medicare beneficiaries, totaling 826 services with total Medicare billing of $37,585. Data is available for 4 years (2020–2023), covering 16 distinct procedure/service records.
Ad
Practice Information
- Specialty Nurse Practitioner
- Location Buffalo, NY
- Active Since 07/24/2006
- Last Updated 01/04/2012
- Taxonomy Code 363L00000X
- Entity Type Individual
- NPI Number 1588686307
Products in Payments
- TRELEGY ELLIPTA (Drug) $96.26
- VOQUEZNA (Drug) $84.54
- TZIELD (Biological) $65.40
- ELIQUIS (Drug) $45.11
- TRULICITY (Drug) $28.82
- ACCRUFER (Drug) $27.29
- RAYALDEE (Drug) $23.31
- JANUVIA (Drug) $23.11
- ENTRESTO (Drug) $21.53
- SUBLOCADE (Drug) $18.12
- Otezla (Drug) $18.01
- UBRELVY (Drug) $15.55
- CAMZYOS (Drug) $14.93
- Omnipod (Device) $13.85
- Rybelsus (Drug) $13.66
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nurse Practitioner Doctors in Buffalo
Maureen Geary, Np, NP
Nurse Practitioner — Payments: $12,726
Nurse Practitioner $12,726
Maggie Ziebold, Fnp, FNP
Nurse Practitioner — Payments: $10,090
Nurse Practitioner $10,090
Amber Mehta, Np-Bc, NP-BC
Nurse Practitioner — Payments: $5,677
Nurse Practitioner $5,677
Lenore Nigrelli, Np, NP
Nurse Practitioner — Payments: $3,661
Nurse Practitioner $3,661
Cory Damon
Nurse Practitioner — Payments: $2,975
Nurse Practitioner $2,975
Ms. Pamela Sheehan-Schreck, Fnp, FNP
Nurse Practitioner — Payments: $1,944
Nurse Practitioner $1,944